RESUMEN
Se presenta el caso clínico de una paciente que consultó por una mancha oscura en la palma izquierda. El examen micológico permitió determinar que la infección había sido producida por un hongo pigmentado, Hortaea werneckii, agente etiológico de la tinea nigra palmaris. Esta es una infección benigna que puede ser rápidamente diagnosticada y tiene tratamiento eficaz. La paciente fue tratada con econazol durante un mes, con remisión completa de las lesiones. Frente a la sospecha de una infección fúngica por la presencia de manchas de color pardo es muy importante practicar el estudio micológico, ya que mediante una técnica no invasora es posible establecer un diagnóstico diferencial y descartar fácilmente otras patologías más graves con las que puede confundirse en el examen clínico.
A clinical case of a female patient with a black spot on the palm of her left hand is presented. The infection was due to a black fungus identified as Hortaea werneckii, the aetiological agent of tinea nigra palmaris. This infection can be easily diagnosed and it is important to establish the differential diagnosis from other skin pathologies. Normally, the treatment has a successful outcome. In this case, the patient was treated with econazole locally applied during one month, with complete remission of the lesions. In conclusion, the early diagnosis of this disease is very important since the mycology procedures are fast and non-invasive and cure is obtained with local treatment.
Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Dermatosis de la Mano/diagnóstico , Tiña/diagnóstico , Antifúngicos/uso terapéutico , Econazol/uso terapéutico , Dermatosis de la Mano/tratamiento farmacológico , Dermatosis de la Mano/microbiología , Hongos Mitospóricos/aislamiento & purificación , Tiña/tratamiento farmacológico , Tiña/microbiologíaRESUMEN
A clinical case of a female patient with a black spot on the palm of her left hand is presented. The infection was due to a black fungus identified as Hortaea werneckii, the aetiological agent of tinea nigra palmaris. This infection can be easily diagnosed and it is important to establish the differential diagnosis from other skin pathologies. Normally, the treatment has a successful outcome. In this case, the patient was treated with econazole locally applied during one month, with complete remission of the lesions. In conclusion, the early diagnosis of this disease is very important since the mycology procedures are fast and non-invasive and cure is obtained with local treatment.
Asunto(s)
Dermatosis de la Mano/diagnóstico , Tiña/diagnóstico , Antifúngicos/uso terapéutico , Econazol/uso terapéutico , Femenino , Dermatosis de la Mano/tratamiento farmacológico , Dermatosis de la Mano/microbiología , Humanos , Persona de Mediana Edad , Hongos Mitospóricos/aislamiento & purificación , Tiña/tratamiento farmacológico , Tiña/microbiologíaRESUMEN
The present study assessed the susceptibility of Candida albicans strains, collected from HIV-positive patients with oral candidiasis, to a commercial 20% ethanol propolis extract (EPE) and compare it to the inhibitory action of the standardized antifungal agents nystatin (NYS), clotrimazole (CL), econazole (EC), and fluconazole (FL). Twelve C. albicans strains collected from HIV-positive patients with oral candidiasis were tested. The inhibition zones were measured with a pachimeter and the results are reported as means and standard deviation (M +/- SD). Data were analyzed statistically by the non-parametric Kruskal-Wallis test. EPE inhibited all the C. albicans strained tested. No significant difference was observed between the results obtained with NYS and EPE, while significant differences were observed between EPE and other antifungals. The C. albicans strains tested showed resistance to the remaining antifungal agents. The propolis extract used in this study inhibited the in vitro growth of C. albicans collected from HIV-seropositive Brazilian patients, creating/forming inhibition zones like those ones formed by NYS. This fact suggests that commercial EPE could be an alternative medicine in the treatment of candidiasis from HIV-positive patients. However, in vivo studies of the effect of EPE are needed to determine its possible effects on the oral mucosa.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Antiinfecciosos/uso terapéutico , Candida albicans/efectos de los fármacos , Candidiasis Bucal/tratamiento farmacológico , Seronegatividad para VIH , Seropositividad para VIH/microbiología , Própolis/uso terapéutico , Antifúngicos/uso terapéutico , Brasil , Candida albicans/clasificación , Candida albicans/crecimiento & desarrollo , Clotrimazol/uso terapéutico , Terapias Complementarias , Farmacorresistencia Fúngica , Econazol/uso terapéutico , Etanol , Fluconazol/uso terapéutico , Humanos , Nistatina/uso terapéutico , Solventes , Estadísticas no ParamétricasRESUMEN
Relatamos um caso de lesao tipo querio do couro cabeludo causada por Acremonium kiliense, em menino sem doenca de base. O diagnostico foi feito pelo exame direto e cultivos do pus e crostas.
Asunto(s)
Humanos , Masculino , Preescolar , Acremonium , Dermatosis del Cuero Cabelludo/diagnóstico , Cuero Cabelludo/lesiones , Econazol/uso terapéutico , Dermatosis del Cuero Cabelludo/patología , Dermatosis del Cuero Cabelludo/terapiaRESUMEN
É feita uma revisäo dos medicamentos tópicos e sistêmicos mais comumente utilizados na terapêutica dermatológica com o objetivo de orientar seu uso na gravidez e lactaçäo
Asunto(s)
Humanos , Femenino , Embarazo , Recién Nacido , Lactante , Cinética , Lactancia , Embarazo/efectos de los fármacos , Teratógenos/farmacología , Fármacos Dermatológicos/efectos adversos , Econazol/uso terapéutico , Recién Nacido , Nistatina/uso terapéuticoRESUMEN
Arthritis induced in hyperimmune rabbits by the intra-articular injection of the specific antigen was associated with a fall in circulating platelet number that lasted up to 60 days. Pretreatment of the animals with indomethacin and econazol at doses that significantly decreased thromboxane levels in the synovial fluids reduced the arthritis-related thrombocytopenia in the acute phase of arthritis. A similar inhibition was seen when L-655,240, a specific Thromboxane A2 antagonist, and BN 52021, a Platelet Activating Factor antagonist were used. The results suggest that both thromboxane and PAF are involved in the mechanisms leading to thrombocytopenia in this experimental model of arthritis.
Asunto(s)
Artritis Experimental/complicaciones , Diterpenos , Trombocitopenia/etiología , Animales , Econazol/uso terapéutico , Femenino , Ginkgólidos , Indoles/uso terapéutico , Indometacina/uso terapéutico , Lactonas/uso terapéutico , Masculino , Factor de Activación Plaquetaria/antagonistas & inhibidores , Factor de Activación Plaquetaria/fisiología , Conejos , Líquido Sinovial/metabolismo , Trombocitopenia/prevención & control , Tromboxano A2/antagonistas & inhibidores , Tromboxano A2/fisiología , Tromboxano B2/fisiologíaRESUMEN
É apresentada uma revisäo da literatura sobre a candidíase vulvovaginal, com maior ênfase ao diagnóstico e tratamento